Physician profile
Margarita Reyes
NPI 1194050179
$66,646.86
in general payments reported to CMS, 2019-2025
8 companies · $41K in 2025
The $41K reported for 2025 was more than what 99% of Geriatric Medicine (Internal Medicine) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.22 · 2020: $13.05 · 2021: $271 · 2022: $2,596 · 2023: $88.93 · 2024: $23K · 2025: $41K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $20K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Consulting Fee: $13K · Travel and Lodging: $12K · Food and Beverage: $2,636.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $19,945.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,200.00 |
| Consulting Fee | $13,295.00 |
| Travel and Lodging | $11,661.94 |
| Food and Beverage | $2,635.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $42,533.05 | 2023-2025 | |
| Lilly USA, LLC | $21,125.40 | 2023-2025 | Kisunla, Amyvid |
| Biogen, INC. | $2,909.37 | 2020-2024 | Aduhelm |
| Otsuka America Pharmaceutical, INC. | $20.09 | 2023 | Rexulti |
| C2n Diagnostics, LLC | $16.09 | 2025 | Precivityad2 |
| Glaxosmithkline, LLC. | $15.52 | 2019 | |
| Circassia INC. | $13.70 | 2019 | |
| Life Molecular Imaging Ltd | $13.64 | 2025 | Neuraceq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margarita Reyes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.